Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Home > Pressemitteilung: New solutions for the RNA medicine of ... At the RNApp graduate school, young researchers are working to make RNA-based drugs safer and more effective.

Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate.

Plus: Eagle Venture Fund raises $18 million to combat human trafficking, Korea-based NECOA launches first home goods showroom ...

Learn more about whether Moderna, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Moderna, Inc. or Zai Lab Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

S&P Global expects inflation to remain closer to 3.0% in 2025 as tariffs result in higher prices along the domestic supply ...

CDMO, AGC Biologics, announced a strategic decision about the large-scale single-use technology it will use at its new ...

COVID-19 vaccination during pregnancy was not associated with major structural birth defects, according to a study published ...